亞洲知識產權資訊網為知識產權業界提供一個一站式網上交易平台,協助業界發掘知識產權貿易商機,並與環球知識產權業界建立聯繫。無論你是知識產權擁有者正在出售您的知識產權,或是製造商需要購買技術以提高操作效能,又或是知識產權配套服務供應商,你將會從本網站發掘到有用的知識產權貿易資訊。

Liquid Cast Biodegradable Drug Delivering Arterial Stent

技術優勢
Custom to the individual artery Complete coverage of arterial surface reducing thrombogenic potential Increased surface area for drug delivery Simple to deliver Cost-effective Degradable, leaving prosthetic-free arterySuccessful in vivo model
詳細技術說明
A biodegradable polymer stent that molds to a freshly angioplastied artery and is designed to release therapeutic drugs locally.  #healthcare #cardiology #materials #polymer #drugdelivery #stent #therapeutics
*Abstract

Northwestern researchers have developed a novel complement for angioplasty. Their technology is a liquid drug-eluting biodegradable stent that polymerizes in vivo and molds to the contour of the freshly angioplastied artery. In addition to serving as a physical stent, its make-up is a biocompatible elastomeric citric acid-based polymer that releases nitric oxide (NO) when placed in the circulation. NO provides several benefits, including the inhibition of platelet aggregation and vascular smooth muscle cell proliferation as well as the stimulation of endothelial cell growth. NO is also a potent vasodilator. Through these functions, NO protects the freshly angioplastied artery from thrombosis and promotes vascular healing. This stent may be delivered by a triple balloon infusion/occlusion catheter, a separate invention that was also developed by Dr. Kibbe specifically for this project (NU2008-175).

*Inventors
Melina Kibbe Guillermo Ameer
國家/地區
美國

欲了解更多信息,請點擊 這裡
移動設備